We're tackling cancer with our unique approach, analyzing surface protein structures in their native disease context, to pinpoint highly specific targets for novel therapeutics.
Our Approach
Discovering Surface Protein Conformations invisible to traditional approaches
Traditional target discovery methods often overlook pathologic differences in protein structure, leaving critical therapeutic opportunities untapped. At Radical Bio, we are pioneering a revolutionary approach by focusing on Surface Protein Conformations (SPCs)—unique, disease-specific protein structures that are invisible to conventional target discovery approaches.
Discover More About us
Structure at the Omics Scale
Novel Targets
Unparalleled Disease Specificity
First-in-class Therapies
Our Approach
Discovering Surface Protein Conformations invisible to traditional approaches
Traditional target discovery methods often overlook pathologic differences in protein structure, leaving critical therapeutic opportunities untapped. At Radical Bio, we are pioneering a revolutionary approach by focusing on Surface Protein Conformations (SPCs)—unique, disease-specific protein structures that are invisible to conventional target discovery approaches.
Discover More About us
Structure at the Omics Scale
Novel Targets
Unparalleled Disease Specificity
First-in-class Therapies
Our Approach
Discovering Surface Protein Conformations invisible to traditional approaches
Traditional target discovery methods often overlook pathologic differences in protein structure, leaving critical therapeutic opportunities untapped. At Radical Bio, we are pioneering a revolutionary approach by focusing on Surface Protein Conformations (SPCs)—unique, disease-specific protein structures that are invisible to conventional target discovery approaches.
Discover More About us
Structure at the Omics Scale
Novel Targets
Unparalleled Disease Specificity
First-in-class Therapies
Our Technology
Exploring the structural surfaceome to identify novel targetable epitopes
Radical Bio employs a patented, high-throughput platform for characterizing the structural surfaceome of diseases to identify novel epitopes for targeted therapeutics.
Learn More
Native-State Structural Proteomics
Leveraging unique protein conformations across the entire population of surface-expressed proteins to enable precision therapeutics
Ultrasensitive Mass Spectrometry
Integrating bottom-up proteomics with structural data at scale to identify disease-specific protein conformers.
Pioneering AI/ML capabilities
Incorporating machine learning-driven sequence design, conformational modeling, and predictive analytics to enhance target selection and drug candidate engineering.
Our Technology
Exploring the structural surfaceome to identify novel targetable epitopes
Radical Bio employs a patented, high-throughput platform for characterizing the structural surfaceome of diseases to identify novel epitopes for targeted therapeutics.
Learn More
Native-State Structural Proteomics
Leveraging unique protein conformations across the entire population of surface-expressed proteins to enable precision therapeutics
Ultrasensitive Mass Spectrometry
Integrating bottom-up proteomics with structural data at scale to identify disease-specific protein conformers.
Pioneering AI/ML capabilities
Incorporating machine learning-driven sequence design, conformational modeling, and predictive analytics to enhance target selection and drug candidate engineering.
Our Technology
Exploring the structural surfaceome to identify novel targetable epitopes
Radical Bio employs a patented, high-throughput platform for characterizing the structural surfaceome of diseases to identify novel epitopes for targeted therapeutics.
Learn More
Native-State Structural Proteomics
Leveraging unique protein conformations across the entire population of surface-expressed proteins to enable precision therapeutics
Ultrasensitive Mass Spectrometry
Integrating bottom-up proteomics with structural data at scale to identify disease-specific protein conformers.
Pioneering AI/ML capabilities
Incorporating machine learning-driven sequence design, conformational modeling, and predictive analytics to enhance target selection and drug candidate engineering.
The next breakthrough target is waiting
Connect with us to learn about unlocking disease-specific targets and explore partnerships to discover the next generation of targeted medicine.
Contact us
The next breakthrough target is waiting
Connect with us to learn about unlocking disease-specific targets and explore partnerships to discover the next generation of targeted medicine.
Contact us
The next breakthrough target is waiting
Connect with us to learn about unlocking disease-specific targets and explore partnerships to discover the next generation of targeted medicine.
Contact us
© Copyright 2024 Radical Bio. All rights reserved.
© Copyright 2024 Radical Bio. All rights reserved.
© Copyright 2024 Radical Bio. All rights reserved.
